MARKET WIRE NEWS

TriSalus Life Sciences, Inc. (TLSI) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-12 20:53:24 ET

TriSalus Life Sciences, Inc. (TLSI)

Q2 2025 Earnings Conference Call

August 12, 2025 04:30 AM ET

Company Participants

David B. Patience - Chief Financial Officer

Jeremy Feffer - Corporate Participant

Mary T. Szela - CEO, President & Director

Richard Marshall - Corporate Participant

Conference Call Participants

William John Plovanic - Canaccord Genuity Corp., Research Division

Presentation

Operator

Good afternoon, and welcome to TriSalus Life Sciences Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. I will now turn the call over to Jeremy Feffer, Managing Director with LifeSci Advisors. Please go ahead, sir....

Read the full article on Seeking Alpha

For further details see:

TriSalus Life Sciences, Inc. (TLSI) Q2 2025 Earnings Call Transcript
TriSalus Life Sciences Inc. Warrant

NASDAQ: TLSIW

TLSIW Trading

-1.27% G/L:

$1.56 Last:

1,306 Volume:

$1.58 Open:

mwn-app Ad 300

TLSIW Latest News

TLSIW Stock Data

$218,310,730
36,224,125
N/A
18
N/A
Medical Equipment & Supplies
Healthcare
US
Westminster

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App